Stock Track | AdaptHealth Plunges 16% Pre-Market on Revenue Miss, Lowered Guidance

Stock Track

Nov 05, 2024

Shares of AdaptHealth Corp. (NASDAQ: AHCO) plummeted 16.45% in pre-market trading on Monday, after the healthcare services company reported mixed third-quarter results and lowered its full-year revenue guidance.

For the third quarter, AdaptHealth posted earnings of $0.40 per share, surpassing analysts' estimates of $0.17 per share. However, the company's revenue of $805.9 million fell short of expectations, missing the consensus estimate of $809.3 million.

More concerning for investors, AdaptHealth slashed its fiscal 2024 revenue guidance to a range of $3.22 billion to $3.26 billion, down from its previous forecast of $3.26 billion to $3.32 billion. The lowered guidance overshadowed the company's better-than-expected earnings, leading to a sharp sell-off in the stock.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1106165587"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1106165587\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1106165587?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-05 22:36","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1106165587","market":"hk","top_or_hot":-1,"title":"Stock Track | AdaptHealth Plunges 16% Pre-Market on Revenue Miss, Lowered Guidance","media":"Stock Track","content":"<p>Shares of AdaptHealth Corp. (NASDAQ: AHCO) plummeted 16.45% in pre-market trading on Monday, after the healthcare services company reported mixed third-quarter results and lowered its full-year revenue guidance.</p>\n\n<p>For the third quarter, AdaptHealth posted earnings of $0.40 per share, surpassing analysts' estimates of $0.17 per share. However, the company's revenue of $805.9 million fell short of expectations, missing the consensus estimate of $809.3 million.</p>\n\n<p>More concerning for investors, AdaptHealth slashed its fiscal 2024 revenue guidance to a range of $3.22 billion to $3.26 billion, down from its previous forecast of $3.26 billion to $3.32 billion. The lowered guidance overshadowed the company's better-than-expected earnings, leading to a sharp sell-off in the stock.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | AdaptHealth Plunges 16% Pre-Market on Revenue Miss, Lowered Guidance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | AdaptHealth Plunges 16% Pre-Market on Revenue Miss, Lowered Guidance\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2024-11-05 22:36</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of AdaptHealth Corp. (NASDAQ: AHCO) plummeted 16.45% in pre-market trading on Monday, after the healthcare services company reported mixed third-quarter results and lowered its full-year revenue guidance.</p>\n\n<p>For the third quarter, AdaptHealth posted earnings of $0.40 per share, surpassing analysts' estimates of $0.17 per share. However, the company's revenue of $805.9 million fell short of expectations, missing the consensus estimate of $809.3 million.</p>\n\n<p>More concerning for investors, AdaptHealth slashed its fiscal 2024 revenue guidance to a range of $3.22 billion to $3.26 billion, down from its previous forecast of $3.26 billion to $3.32 billion. The lowered guidance overshadowed the company's better-than-expected earnings, leading to a sharp sell-off in the stock.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"AHCO","symbol_name":"AdaptHealth Corp.","start_time":0,"source_url":"","article_id":"1106165587","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1106165587","pubTimestamp":1730817390,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of AdaptHealth Corp.  plummeted 16.45% in pre-market trading on Monday, after the healthcare services company reported mixed third-quarter results and lowered its full-year revenue guidance.For the third quarter, AdaptHealth posted earnings of $0.40 per share, surpassing analysts' estimates of $0.17 per share. However, the company's revenue of $805.9 million fell short of expectations, missing the consensus estimate of $809.3 million.More concerning for investors, AdaptHealth slashed its ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"AHCO":"AdaptHealth Corp."},"translate_title":"AdaptHealth股价盘前暴跌16%，原因是营收未达预期，指引下调","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AHCO":1},"content_text":"Shares of AdaptHealth Corp. (NASDAQ: AHCO) plummeted 16.45% in pre-market trading on Monday, after the healthcare services company reported mixed third-quarter results and lowered its full-year revenue guidance.\nFor the third quarter, AdaptHealth posted earnings of $0.40 per share, surpassing analysts' estimates of $0.17 per share. However, the company's revenue of $805.9 million fell short of expectations, missing the consensus estimate of $809.3 million.\nMore concerning for investors, AdaptHealth slashed its fiscal 2024 revenue guidance to a range of $3.22 billion to $3.26 billion, down from its previous forecast of $3.26 billion to $3.32 billion. The lowered guidance overshadowed the company's better-than-expected earnings, leading to a sharp sell-off in the stock.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}